when intellia therapeutics submit bla for lonvo-z
before September
when intellia therapeutics submit bla for lonvo-z. Best Yes near 46¢ across 1 platform. Live cross-platform prices. Not financial advice.
Best Yes: 46¢ · Best No: 64¢ · 1 platform
- Kalshi: Yes 46¢ / No 64¢
LIVE
before September
Volume
$546
$0 24h
Platforms
1
Cross-platform pricing
Resolution
Resolves Sep 1, 2026
~78 days left
Category
Culture
Yes
46¢
Kalshi
No
64¢
Kalshi
Opens on best-price platform
Compare & Trade
1 platform
Price History
Loading…
About This Market
If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Sep 1, 2026, then the market resolves to Yes.
Market Details
ResolutionResolves Sep 1, 2026
Time Left78 days
Status● Active
CategoryCulture
Yes
46¢
Kalshi
Payout 2.2x
No
64¢
Kalshi
Payout 1.6x
Opens on best-price platform
Compare & Trade
1 platformSign in to join the discussion
Sign In